In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 25, No. 9 ( 2005-09), p. 1897-1902
Kurzfassung:
In a dyslipidemic nondiabetic murine model characterized by macrophage-laden atherosclerotic lesions, we show that fenofibrate, but not rosiglitazone or pioglitazone, delays lesional lipid and macrophage accumulation.
Materialart:
Online-Ressource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/01.ATV.0000175756.56818.ee
Sprache:
Englisch
Verlag:
Ovid Technologies (Wolters Kluwer Health)
Publikationsdatum:
2005
ZDB Id:
1494427-3
Permalink